Perugi G, Medda P, Toni C, Mariani M, Socci C, Mauri M
doi: 10.1016/j.redox.2024.103211 Summary Keywords ferropotosis, AKI, CKD, renal tumor, therapeutic translation, oxidative stress, iron metabolism Citation Luo Y, Long M, Wu X and Zeng L (2025) Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases
Outcome analysis conducted at 1 year or 3 years post-transplant showed consistent results
We found that cell viability was significantly restored by ferroptosis inhibitor ferrostatin-1 (Fer-1) treatment in ACTL6A-ablated cells but not by apoptosis inhibitor ZVAD-FMK or necroptosis inhibitor necrostatin-1 treatment (Fig
GLP-1s are generally well-tolerated with manageable side effects